Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04317534
Brief Title: Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cm

First Submitted : March 19, 2020
First Submitted that Met QC Criteria : March 19, 2020
First Posted : March 23, 2020

Last Update Submitted that Met QC Criteria : December 6, 2021
Last Update Posted : December 7, 2021 (Estimate)